TGF-β : Titan of Lung Fibrogenesis
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Pulmonary fibrosis is characterized by epithelial cell injury, accumulation of myofibroblasts, and excessive deposition of collagen and other extracellular matrix elements, leading to loss of pulmonary function. Studies in both humans and animal models strongly suggest that TGF-β1 plays a pivotal role in the pathogenesis of pulmonary fibrosis. This review will first give an overview of TGF-β signaling and the effects of its inhibition on lung fibrogenesis. This overview includes information on TGF-β signal transduction pathways, the importance of TGF-β in the accumulation of myofibroblasts, the role of TGF-β in epithelial injury and apoptosis, the role of TGF-β in extracellular matrix remodeling, and the effects of inhibiting TGF-β signaling in animal models of lung fibrosis. Subsequently this review will highlight recent advances in two areas of particular interest to our research group: (1) TGF-β and proteoglycans; (2) TGF-β and histone deacetylases. Although our understanding of the role of TGF-β and its mechanisms of action in lung fibrogenesis has increased dramatically in recent years, there is still much to be learned about this important molecule, especially how TGF-β function is modulated in vivo, and its complex interactions with other factors expressed during lung injury and repair. Research in these areas will help identify novel therapeutic targets for the treatment of pulmonary fibrosis that will hopefully improve the prognosis of this devastating illness. Keywo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By increasing glutathione levels, sodium pyruvate nasal spray, does reduce ROS in the airway epithelium [112]. A small study of 15 patients with either pulmonary fibrosis and COPD or pulmonary fibrosis alone received sodium pyruvate nasal spray and had baseline FEV1, FVC, peak expiratory flow (PEF), FEV1/FVC ratios, peripheral oxygen saturation, exhaled nitric oxide levels, coughing rates, and”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [112]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Ghosh, A. K., & Vaughan, D. E. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22783 · Cited by 679
Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer
Buechler, M. B., Fu, W., & Turley, S. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.021 · Cited by 494
Lung Fibrosis after COVID-19: Treatment Prospects
Bazdyrev, E., Rusina, P., Panova, M., Novikov, F., Grishagin, I., & Nebolsin, V. (2021) · Pharmaceuticals · doi:10.3390/ph14080807 · Cited by 192
Molecular basis of organ fibrosis: Potential therapeutic approaches
Ghosh, A. K., Quaggin, S. E., & Vaughan, D. E. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213489441 · Cited by 155
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
Saito, S., Zhuang, Y., Shan, B., Danchuk, S. D., Luo, F., Korfei, M., Günther, A., & Lasky, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186615 · Cited by 127
Self-citation
Metadata
- Authors
- Yue, X., Shan, B., & A. Lasky, J.
- Venue
- Current Enzyme Inhibition
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-07-01
- Volume
- 6
- Issue
- 2
- Pages
- 67-77
- ISSN
- 1573-4080 (ISSN-L)
- OpenAlex
- W4243733521
- Cited by
- 130
- References
- 0
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 16 · 2023: 27 · 2022: 18 · 2021: 10 · 2020: 13 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 1 · 2014: 1 · 2013: 2
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Enzyme Inhibition (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- TGF-β1, pulmonary fibrosis, lung fibrogenesis, myofibroblast accumulation, epithelial damage, apoptosis, extracellular matrix remodeling, TGF-beta signaling, TGF-beta inhibition, epithelial-mesenchymal transition, integrins, reactive oxygen species, proteoglycans, sulfation, histone deacetylase, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TGF-β : Titan of Lung Fibrogenesis. https://app.cochat.ai/papers/10.2174/157340810791233033
- The paper
- Yue, X., Shan, B., & A. Lasky, J. (2010). TGF-β : Titan of Lung Fibrogenesis. Current Enzyme Inhibition. https://doi.org/10.2174/157340810791233033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.